echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The evaluation of basic medicines in tertiary hospitals has changed!

    The evaluation of basic medicines in tertiary hospitals has changed!

    • Last Update: 2022-05-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The evaluation of essential medicines is once again mentioned in the evaluation index system of tertiary public hospitals.
    So, can essential medicines be fully equipped and used in tertiary hospitals in the future? This is an issue worth considering by the industry
    .
     
    Recently, the General Office of the National Health and Medical Commission issued the "Notice on Printing and Distributing the Performance Assessment Operation Manual of National Tertiary Public Hospitals (2022 Edition)", with a total of 56 performance assessment indicators and a total score of 560 points
    .
     
    Among them, there are three indicators related to the use of essential drugs, namely:
     
    (18) Proportion of essential drug prescriptions for outpatients
     
    (19) Utilization rate of essential medicines in hospitalized patients
     
    (20) Proportion of purchased varieties of essential medicines
     
    Among these three indicators, items (18) and (19) existed before, and item (20) was added on the basis of the 2020 version
    .
     
    In fact, in the report on the assessment of tertiary public hospitals in 2018 published by the National Health Commission, the above (18) and (19) described:
     
    The ratio of review prescriptions to the total number of prescriptions, the review rate of ward (district) doctor orders (prescriptions), the number and proportion of essential medicines purchased have increased year by year, and the proportion of essential medicine prescriptions for outpatients has reached 52.
    25% (this indicator refers to the number of essential medicines available.
    The ratio of prescriptions to total prescriptions), and the utilization rate of essential medicines in hospitalized patients reached 95.
    38% (this indicator refers to the proportion of the number of patients who contained essential medicines in their medication during hospitalization to the total number of discharged patients)
    .
     
      It can be seen that in the assessment data in 2018, whether it is an outpatient department or an inpatient department, as long as a prescription contains more than one basic drug variety, it can be included in the index statistics
    .
    Therefore, although these two indicators seem to be done well, especially the use of essential drugs in hospital, it is not difficult to achieve
    .
     
      These two assessment indicators continue to be used in the 2022 version of the assessment, but the corresponding two varieties of quantity indicators are extended
    .
     
     
      In addition, the 2022 version of the new indicators for essential drugs: (20) The proportion of the number of varieties of essential drugs purchased is also about the proportion of the number of varieties, and the indicators are extended to the proportion of the amount, these are all "hard indicators", the most It can reflect the actual use of essential drugs in tertiary hospitals
    .
    Rather than the "symbolic meaning" of items (18) and (19) is greater than the actual meaning
    .
     
     
      When the 2018 version of the tertiary hospital index assessment was issued, the "1+X" and "9-8-6" basic drug allocation requirements for basic drugs had not yet been introduced (it was only introduced in the document on shortage drug management in 2019), At that time, items (18) and (19) did not have extended indicators for the assessment of the number of varieties.
    Therefore, the assessment of tertiary hospitals seemed to have been completed fairly well
    .
     
      However, the 2022 version of the assessment indicators are now released under the background of the "1+X" and "9-8-6" basic medicine allocation policies, and this policy is also clearly mentioned in the notice
    .
     
     
      It is worth noting that 2022 is also a "big year" for the adjustment of the new version of the Essential Drug List.
    On the basis of the 2018 version of the 685 Essential Drug List, in line with the new requirements of "1+X" and "9-8-6", The list of essential medicines may face expansion
    .
     
      The importance of essential medicines in the future will be much greater than in the past.
    Combined with the current policies, essential medicines have the following advantages that cannot be ignored:
     
      1) With the continuous improvement of policies such as essential drugs, centralized procurement, and national consultation, the clinical drug structure is basically clear, and the policy intends to form such a drug orientation.
    Please pay attention to the order: basic drugs, centralized procurement varieties, national consultation varieties, medical insurance varieties, Non-medical insurance varieties
    .
    Essential drugs occupy a favorable position in the first order of medication in all categories;
     
      2) With the introduction of the "1+X" model and the equipment requirements of "9-8-6", various provinces and cities have continuously introduced policies to improve them, and the assessment of public hospitals has become increasingly strict, whether it is a tertiary hospital.
    It is also a primary medical institution.
    Under the strict control of the three detailed assessments of the proportion of prescriptions, the proportion of quantity, and the proportion of the amount of basic drugs, the allocation and use indicators of basic drugs will greatly improve the execution;
     
      3) Through 6 batches and 7 rounds of national procurement and provincial centralized procurement, centralized procurement has been established as the dominant procurement method.
    In the future, hospital selection of drugs will be more institutionalized, process-based and batch-oriented, and sporadic hospital access will be difficult to operate
    .
    However, having the attributes of essential medicines still occupies the advantage of policy encouragement, not to mention that more than half of the collected varieties are essential medicines, which has an unparalleled advantage in hospital admission;
     
      4) The policy encouragement and even special treatment of basic drugs, centralized procurement, and national consultations have been established for clinical use (for example, the varieties of centralized procurement and national consultations can break through the restrictions of one product and two regulations, and preferential treatment for medical insurance payment), and there are also differences in access and use among them.
    Competition, especially under the DRG/DIP payment model
    .
    At this time, the basic drugs may not generate more than expected sales, but can maintain the hospital's upper limit of the number of drugs (1500/1200/800), and the hospital has to consider the issue of the number of basic drugs in the drug structure;
     
      5) However, two things have to be said in the end: First, do not have too many expectations on the sales of essential drugs; second, it is not advisable to enter the essential drug list and then enter the medical insurance list.
    You can calculate the time.
    cost, institutional cost, and opportunity cost?
      The evaluation of essential medicines is once again mentioned in the evaluation index system of tertiary public hospitals.
    So, can essential medicines be fully equipped and used in tertiary hospitals in the future? This is an issue worth considering by the industry
    .
     
      Recently, the General Office of the National Health and Medical Commission issued the "Notice on Printing and Distributing the Performance Assessment Operation Manual of National Tertiary Public Hospitals (2022 Edition)", with a total of 56 performance assessment indicators and a total score of 560 points
    .
     
      Among them, there are three indicators related to the use of essential drugs, namely:
     
       (18) Proportion of essential drug prescriptions for outpatients
     
       (19) Utilization rate of essential medicines in hospitalized patients
     
       (20) Proportion of purchased varieties of essential medicines
     
      Among these three indicators, items (18) and (19) existed before, and item (20) was added on the basis of the 2020 version
    .
     
      In fact, in the report on the assessment of tertiary public hospitals in 2018 published by the National Health Commission, the above (18) and (19) described:
     
      The ratio of review prescriptions to the total number of prescriptions, the review rate of ward (district) doctor orders (prescriptions), the number and proportion of essential medicines purchased have increased year by year, and the proportion of essential medicine prescriptions for outpatients has reached 52.
    25% (this indicator refers to the number of essential medicines available.
    The ratio of prescriptions to total prescriptions), and the utilization rate of essential medicines in hospitalized patients reached 95.
    38% (this indicator refers to the proportion of the number of patients who contained essential medicines in their medication during hospitalization to the total number of discharged patients)
    .
     
      It can be seen that in the assessment data in 2018, whether it is an outpatient department or an inpatient department, as long as a prescription contains more than one basic drug variety, it can be included in the index statistics
    .
    Therefore, although these two indicators seem to be done well, especially the use of essential drugs in hospital, it is not difficult to achieve
    .
     
      These two assessment indicators continue to be used in the 2022 version of the assessment, but the corresponding two varieties of quantity indicators are extended
    .
     
     
      In addition, the 2022 version of the new indicators for essential drugs: (20) The proportion of the number of varieties of essential drugs purchased is also about the proportion of the number of varieties, and the indicators are extended to the proportion of the amount, these are all "hard indicators", the most It can reflect the actual use of essential drugs in tertiary hospitals
    .
    Rather than the "symbolic meaning" of items (18) and (19) is greater than the actual meaning
    .
     
     
      When the 2018 version of the tertiary hospital index assessment was issued, the "1+X" and "9-8-6" basic drug allocation requirements for basic drugs had not yet been introduced (it was only introduced in the document on shortage drug management in 2019), At that time, items (18) and (19) did not have extended indicators for the assessment of the number of varieties.
    Therefore, the assessment of tertiary hospitals seemed to have been completed fairly well
    .
     
      However, the 2022 version of the assessment indicators are now released under the background of the "1+X" and "9-8-6" basic medicine allocation policies, and this policy is also clearly mentioned in the notice
    .
     
     
      It is worth noting that 2022 is also a "big year" for the adjustment of the new version of the Essential Drug List.
    On the basis of the 2018 version of the 685 Essential Drug List, in line with the new requirements of "1+X" and "9-8-6", The list of essential medicines may face expansion
    .
     
      The importance of essential medicines in the future will be much greater than in the past.
    Combined with the current policies, essential medicines have the following advantages that cannot be ignored:
     
      1) With the continuous improvement of policies such as essential drugs, centralized procurement, and national consultation, the clinical drug structure is basically clear, and the policy intends to form such a drug orientation.
    Please pay attention to the order: basic drugs, centralized procurement varieties, national consultation varieties, medical insurance varieties, Non-medical insurance varieties
    .
    Essential drugs occupy a favorable position in the first order of medication in all categories;
     
      2) With the introduction of the "1+X" model and the equipment requirements of "9-8-6", various provinces and cities have continuously introduced policies to improve them, and the assessment of public hospitals has become increasingly strict, whether it is a tertiary hospital.
    It is also a primary medical institution.
    Under the strict control of the three detailed assessments of the proportion of prescriptions, the proportion of quantity, and the proportion of the amount of basic drugs, the allocation and use indicators of basic drugs will greatly improve the execution;
     
      3) Through 6 batches and 7 rounds of national procurement and provincial centralized procurement, centralized procurement has been established as the dominant procurement method.
    In the future, hospital selection of drugs will be more institutionalized, process-based and batch-oriented, and sporadic hospital access will be difficult to operate
    .
    However, having the attributes of essential medicines still occupies the advantage of policy encouragement, not to mention that more than half of the collected varieties are essential medicines, which has an unparalleled advantage in hospital admission;
     
      4) The policy encouragement and even special treatment of basic drugs, centralized procurement, and national consultations have been established for clinical use (for example, the varieties of centralized procurement and national consultations can break through the restrictions of one product and two regulations, and preferential treatment for medical insurance payment), and there are also differences in access and use among them.
    Competition, especially under the DRG/DIP payment model
    .
    At this time, the basic drugs may not generate more than expected sales, but can maintain the hospital's upper limit of the number of drugs (1500/1200/800), and the hospital has to consider the issue of the number of basic drugs in the drug structure;
     
      5) However, two things have to be said in the end: First, do not have too many expectations on the sales of essential drugs; second, it is not advisable to enter the essential drug list and then enter the medical insurance list.
    You can calculate the time.
    cost, institutional cost, and opportunity cost?
      The evaluation of essential medicines is once again mentioned in the evaluation index system of tertiary public hospitals.
    So, can essential medicines be fully equipped and used in tertiary hospitals in the future? This is an issue worth considering by the industry
    .
     
      Recently, the General Office of the National Health and Medical Commission issued the "Notice on Printing and Distributing the Performance Assessment Operation Manual of National Tertiary Public Hospitals (2022 Edition)", with a total of 56 performance assessment indicators and a total score of 560 points
    .
     
      Among them, there are three indicators related to the use of essential drugs, namely:
     
       (18) Proportion of essential drug prescriptions for outpatients
     
       (19) Utilization rate of essential medicines in hospitalized patients
     
       (20) Proportion of purchased varieties of essential medicines
     
      Among these three indicators, items (18) and (19) existed before, and item (20) was added on the basis of the 2020 version
    .
     
      In fact, in the report on the assessment of tertiary public hospitals in 2018 published by the National Health Commission, the above (18) and (19) described:
     
      The ratio of review prescriptions to the total number of prescriptions, the review rate of ward (district) doctor orders (prescriptions), the number and proportion of essential medicines purchased have increased year by year, and the proportion of essential medicine prescriptions for outpatients has reached 52.
    25% (this indicator refers to the number of essential medicines available.
    The ratio of prescriptions to total prescriptions), and the utilization rate of essential medicines in hospitalized patients reached 95.
    38% (this indicator refers to the proportion of the number of patients who contained essential medicines in their medication during hospitalization to the total number of discharged patients)
    .
     
      It can be seen that in the assessment data in 2018, whether it is an outpatient department or an inpatient department, as long as a prescription contains more than one basic drug variety, it can be included in the index statistics
    .
    Therefore, although these two indicators seem to be done well, especially the use of essential drugs in hospital, it is not difficult to achieve
    .
    medicines medicines medicines
     
      These two assessment indicators continue to be used in the 2022 version of the assessment, but the corresponding two varieties of quantity indicators are extended
    .
     
     
      In addition, the 2022 version of the new indicators for essential drugs: (20) The proportion of the number of varieties of essential drugs purchased is also about the proportion of the number of varieties, and the indicators are extended to the proportion of the amount, these are all "hard indicators", the most It can reflect the actual use of essential drugs in tertiary hospitals
    .
    Rather than the "symbolic meaning" of items (18) and (19) is greater than the actual meaning
    .
    hospital hospital hospital
     
     
      When the 2018 version of the tertiary hospital index assessment was issued, the "1+X" and "9-8-6" basic drug allocation requirements for basic drugs had not yet been introduced (it was only introduced in the document on shortage drug management in 2019), At that time, items (18) and (19) did not have extended indicators for the assessment of the number of varieties.
    Therefore, the assessment of tertiary hospitals seemed to have been completed fairly well
    .
     
      However, the 2022 version of the assessment indicators are now released under the background of the "1+X" and "9-8-6" basic medicine allocation policies, and this policy is also clearly mentioned in the notice
    .
     
     
      It is worth noting that 2022 is also a "big year" for the adjustment of the new version of the Essential Drug List.
    On the basis of the 2018 version of the 685 Essential Drug List, in line with the new requirements of "1+X" and "9-8-6", The list of essential medicines may face expansion
    .
     
      The importance of essential medicines in the future will be much greater than in the past.
    Combined with the current policies, essential medicines have the following advantages that cannot be ignored:
     
      1) With the continuous improvement of policies such as essential drugs, centralized procurement, and national consultation, the clinical drug structure is basically clear, and the policy intends to form such a drug orientation.
    Please pay attention to the order: basic drugs, centralized procurement varieties, national consultation varieties, medical insurance varieties, Non-medical insurance varieties
    .
    Essential drugs occupy a favorable position in the first order of medication in all categories;
     
      2) With the introduction of the "1+X" model and the equipment requirements of "9-8-6", various provinces and cities have continuously introduced policies to improve them, and the assessment of public hospitals has become increasingly strict, whether it is a tertiary hospital.
    It is also a primary medical institution.
    Under the strict control of the three detailed assessments of the proportion of prescriptions, the proportion of quantity, and the proportion of the amount of basic drugs, the allocation and use indicators of basic drugs will greatly improve the execution;
     
      3) Through 6 batches and 7 rounds of national procurement and provincial centralized procurement, centralized procurement has been established as the dominant procurement method.
    In the future, hospital selection of drugs will be more institutionalized, process-based and batch-oriented, and sporadic hospital access will be difficult to operate
    .
    However, having the attributes of essential medicines still occupies the advantage of policy encouragement, not to mention that more than half of the collected varieties are essential medicines, which has an unparalleled advantage in hospital admission;
    purchase purchase purchase
     
      4) The policy encouragement and even special treatment of basic drugs, centralized procurement, and national consultations have been established for clinical use (for example, the varieties of centralized procurement and national consultations can break through the restrictions of one product and two regulations, and preferential treatment for medical insurance payment), and there are also differences in access and use among them.
    Competition, especially under the DRG/DIP payment model
    .
    At this time, the basic drugs may not generate more than expected sales, but can maintain the hospital's upper limit of the number of drugs (1500/1200/800), and the hospital has to consider the issue of the number of basic drugs in the drug structure;
     
      5) However, two things have to be said in the end: First, do not have too many expectations on the sales of essential drugs; second, it is not advisable to enter the essential drug list and then enter the medical insurance list.
    You can calculate the time.
    cost, institutional cost, and opportunity cost?
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.